Deal Watch: GSK Makes $85m Wager On Surface’s Preclinical NK Cell Therapy

 
• By Joseph Haas, Ian Haydock, and Jung Won Shin
  
DealWatch_1200x675
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business